The Latest Cardiac and Vascular News
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–AtaCor Medical, Inc. (www.atacor.com) announced today that it has completed a $8.8M Series A financing. Co-led by Boston-based Broadview Ventures and Israel-based aMoon Ventures, the financing also includes participation from a corporate partner. The investment will support the continued development of AtaCor’s revolutionary extravascular substernal cardiac pacing […]
LISLE, Ill., Sept. 14, 2018 /PRNewswire/ — Endotronix, Inc., a digital health, medtech company dedicated to advancing the treatment of heart failure, today announced the close of a Series D financing round totaling $45 million. The round was led by LSP, investing from its LSP Health Economics Fund 2, and included Aperture Venture Partners, BioVentures Investors, Lumira Ventures, OSF […]
Ken Dropiewski Principal Consultant Life Science/Medical Device Practice Executive Summary: In January 2018, President Trump issued an Executive Order suspending the medical device tax (2.3% on revenue) for an additional 24 months. Further, because the moratorium is retroactive to January 1, 2018 -when the tax did commence, medical device […]
BAAR, Switzerland–(BUSINESS WIRE)–CorFlow Therapeutics AG (www.corflow-therapeutics.ch) today announced that the company has completed the 2nd close of its Seed+ financing round. To date, and since the CorFlow foundation in 2016, the company has raised a total of USD 9.7M (CHF 9.4M) in seed funding. The seed rounds have been funded by experienced private […]
Santa Monica, CA, Sept. 10, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB: BSGM, OTCQB: BSGMD) (“BioSig” or the “Company”), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company […]
Santa Monica, CA, Sept. 11, 2018 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (OTCQB:BSGM, OTCQB:BSGMD) a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet technology need for the $4.6 billion electrophysiology (EP) marketplace, today announced that the Company has issued their September 2018 letter […]
VANCOUVER, Sept. 11, 2018 /PRNewswire/ – Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ : NVCN )(TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, announced today (1) that it has received the decision of the […]
BOSTON–(BUSINESS WIRE)–InfoBionic, a digital health company focused on patient-monitoring solutions for chronic disease management, today announced the completion of a $50 million financing to support continued commercial expansion of its MoMe® Kardia system for remote, wireless outpatient monitoring and diagnosis of cardiac arrhythmias. The financing round includes participation by Eagle Investments; Excel Venture Management; Safeguard Scientifics; Zaffre […]
ALAMEDA, Calif. – September 4, 2018 – Penumbra, Inc. (NYSE: PEN), a global healthcare company focused on innovative therapies, today announced it has closed on the acquisition of a controlling interest in its joint venture, MVI Health Inc. After closing the transaction, Penumbra increased its ownership to 90 percent of […]
MINNEAPOLIS, Sept. 10, 2018 /PRNewswire/ — 4C Medical Technologies, Inc. (4C Medical), a privately-held medical technology company focused on the development of minimally invasive therapies for structural heart disease, today announced that it completed a private placement of shares of its Series A Preferred Stock earlier this week, resulting in total gross proceeds […]
